Research and Transparency Required for 340B Program
The federal 340B Drug Pricing Program allows qualifying entities that treat low-income and uninsured patients to buy outpatient prescription drugs at a discount according...
Forecasting Gene Therapy Candidates Using Claims Data and Other Sources
More than 30 gene therapies are currently approved by the FDA, with more than 2,000 others in development. Many have high list prices at...
Evaluating Coverage for Prescription Digital Therapeutics
Digital health is a new frontier in health care, continually bringing new tools to the market, with the promise of many more in the...
Specialty Drug Use Varies by Race and Wage
New research presented at AMCP Nexus 2023 indicates that race and ethnicity and wage-related disparities may be related to lower use of specialty medications...